News

The CE mark clearance from the EU certifies that Elekta Compact has met health, safety and environmental requirements for consumer safety. Elekta Compact was developed to address the

TomoDirect is an innovative new discrete-angle, sliding-beam delivery mode for the HiArt treatment system. With this capability, clinicians are said to gain an efficient complement to helical TomoTherapy,

Nathaniel Cady, assistant professor of nanobioscience at College of Nanoscale Science and Engineering (CNSE), will lead the research efforts in collaboration with assistant professor of nanobioscience Magnus Bergkvist.

The newly appointed directors are expected to add deep operational and commercial expertise to the board as Targanta continues to build its infrastructure in support of the potential

Ms Harris will assume responsibility for Symmetry’s consolidated financials, external reporting and standardizing global accounting. Prior to joining Symmetry, Ms Harris served as assistant controller of General Electric’s

The Phase I trial is designed as an open-label dose escalation study of CUDC-101 in patients with advanced, refractory solid tumors. CUDC-101 will be administered on days one

DiagnoCure Oncology Laboratories will promote and offer the test directly to clinicians across the US. The sales team can now actively promote the test, and the company’s US

Mr Spring joins Prometheus with 25 years of experience in finance and accounting. He comes most recently from Hyperion Therapeutics, where he served as senior vice president and

This multicenter, randomized open-label Phase II single-arm study is enrolling patients with metastatic androgen-independent prostate cancer who have developed disease progression during or within 60 days of receiving